Advancing Novel Treatments for Endocrine Disorders

Spruce is building a sustainable pipeline of treatments for patients suffering from rare endocrine disorders. Our portfolio includes first- and best-in-class small molecules.

Now Enrolling Patients for

Congenital Adrenal Hyperplasia Clinical Trials 2018

If you are an adult with a genetic diagnosis of classic Congenital Adrenal Hyperplasia, you may be eligible to participate in a Phase 2 clinical trial for a new therapy for CAH. To be notified when a site opens near you, sign up for our mailing list.

Our Phase 2 program has active sites in San Diego, CA, Orange, CA, Las Vegas, NV, Atlanta, GA, Indianapolis, IN, Minneapolis, MN, Melbourne, FL.

Learn More

Spruce Biosciences is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders. We are leveraging our extensive expertise in endocrinology and orphan drug development to meet the significant unmet need of patients suffering from these diseases. We are committed to transforming the quality of life for patients who have been underserved by scientific innovation.